Responses
Clinical and epidemiological research
Extended report
Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study
Compose a Response to This Article
Other responses
No responses have been published for this article.